These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1052 related articles for article (PubMed ID: 27328803)
1. Prevalence of systemic autoimmune rheumatic diseases and clinical significance of ANA profile: data from a tertiary hospital in Shanghai, China. Yang Z; Ren Y; Liu D; Lin F; Liang Y APMIS; 2016 Sep; 124(9):805-11. PubMed ID: 27328803 [TBL] [Abstract][Full Text] [Related]
2. [Investigation of the Contribution of Autoantibodies to Clinical Diagnosis in Liver Pathologies and the Identification of Accompanying Autoimmune Diseases]. Duran A; Çetin Duran A; Taşkıran İ Mikrobiyol Bul; 2022 Jan; 56(1):81-94. PubMed ID: 35088962 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat, Morocco. Missoum H; Alami M; Bachir F; Arji N; Bouyahya A; Rhajaoui M; El Aouad R; Bakri Y Hum Immunol; 2019 Jul; 80(7):523-532. PubMed ID: 30807792 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD). Seelig CA; Bauer O; Seelig HP Clin Lab; 2016; 62(4):499-517. PubMed ID: 27215068 [TBL] [Abstract][Full Text] [Related]
5. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil- lymphocyte ratios among various systemic autoimmune rheumatic diseases. Yang Z; Zhang Z; Lin F; Ren Y; Liu D; Zhong R; Liang Y APMIS; 2017 Oct; 125(10):863-871. PubMed ID: 28766758 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases. Sulcebe G; Morcka K Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070 [TBL] [Abstract][Full Text] [Related]
7. Analysis of antinuclear antibody titers and patterns by using HEp-2 and primate liver tissue substrate indirect immunofluorescence assay in patients with systemic autoimmune rheumatic diseases. Wei Q; Jiang Y; Xie J; Lv Q; Xie Y; Tu L; Xiao M; Wu Z; Gu J J Clin Lab Anal; 2020 Dec; 34(12):e23546. PubMed ID: 33047841 [TBL] [Abstract][Full Text] [Related]
8. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381 [TBL] [Abstract][Full Text] [Related]
9. Association of Immunofluorescence pattern of Antinuclear Antibody with Specific Autoantibodies in the Bangladeshi Population. Sharmin S; Ahmed S; Abu Saleh A; Rahman F; Choudhury MR; Hassan MM Bangladesh Med Res Counc Bull; 2014 Aug; 40(2):74-8. PubMed ID: 26415344 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence and diagnostic value of antinuclear antibodies without identified antigenic target: a retrospective study of 90 patients]. Feki S; Frikha F; Ben Hadj Hmida Y; Abed S; Ben Ayed M; Turki H; Hachicha J; Baklouti S; Bahloul Z; Masmoudi H Rev Med Interne; 2012 Sep; 33(9):475-81. PubMed ID: 22658165 [TBL] [Abstract][Full Text] [Related]
11. Identification of specific antinuclear antibodies in dogs using a line immunoassay and enzyme-linked immunosorbent assay. Bremer HD; Lattwein E; Renneker S; Lilliehöök I; Rönnelid J; Hansson-Hamlin H Vet Immunol Immunopathol; 2015 Dec; 168(3-4):233-41. PubMed ID: 26547884 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti-NT5C1A antibodies in Japanese patients with autoimmune rheumatic diseases in comparison with other patient cohorts. Muro Y; Nakanishi H; Katsuno M; Kono M; Akiyama M Clin Chim Acta; 2017 Sep; 472():1-4. PubMed ID: 28687351 [TBL] [Abstract][Full Text] [Related]
13. Application of linear discriminant analysis in performance evaluation of extractable nuclear antigen immunoassay systems in the screening and diagnosis of systemic autoimmune rheumatic diseases. Pi D; de Badyn MH; Nimmo M; White R; Pal J; Wong P; Phoon C; O'Connor D; Pi S; Shojania K Am J Clin Pathol; 2012 Oct; 138(4):596-603. PubMed ID: 23010715 [TBL] [Abstract][Full Text] [Related]
14. Clinical and serological heterogeneity in patients with anticentromere antibodies. Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324 [TBL] [Abstract][Full Text] [Related]
15. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
16. Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases. Peker BO; Şener AG; Tarhan EF; Kaya S Clin Rheumatol; 2019 Dec; 38(12):3627-3633. PubMed ID: 31396837 [TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibody titration and pattern are helpful in the diagnosis of systemic autoimmune rheumatic diseases. Mohd Razi MS; Sugumaran Y; Mohd Haniz NA; Khilmie K; Osmera AH; Jauhary EJ; Wahab AA Malays J Pathol; 2024 Apr; 46(1):63-69. PubMed ID: 38682845 [TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Bodolay E; Csiki Z; Szekanecz Z; Ben T; Kiss E; Zeher M; Szücs G; Dankó K; Szegedi G Clin Exp Rheumatol; 2003; 21(3):313-20. PubMed ID: 12846049 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to the extractable nuclear antigens (ENA) in Pakistani patients with systemic rheumatic disease. Ahmed TA; Malik IA; Saleem M; Khan AA; Hameed A; Shah ST; Amin SJ; Farooqi A J Pak Med Assoc; 1995 Jan; 45(1):12-4. PubMed ID: 7731078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]